Literature DB >> 17072502

Mammalian toll-like receptors: from endogenous ligands to tissue regeneration.

Z Zhang1, H J Schluesener.   

Abstract

Following injury a complex but well-orchestrated cellular response stimulating wound healing and tissue regeneration is induced. The balance of different cytokines, growth factors and cells is important in regulating tissue reorganisation. The immune system is critically involved in this process. Toll-like receptors (TLRs) are essential to the innate immune system, recognising microbial pathogens. The recent identification of endogenous ligands of TLRs suggests that they function not only to induce defensive antimicrobial immune responses but also as a sensitive detection system to initiate tissue regeneration after injury. Here we present an overview of TLRs and their endogenous ligands, and also review the roles of TLRs in inducing tissue regeneration after injury and in maintaining homeostasis. The identification of endogenous TLR ligands and their involvement in inducing tissue regeneration will provide new options to improve tissue reorganization after injury.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17072502     DOI: 10.1007/s00018-006-6189-1

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  33 in total

1.  Identification of novel synthetic toll-like receptor 2 agonists by high throughput screening.

Authors:  Yue Guan; Katherine Omueti-Ayoade; Sarita K Mutha; Paul J Hergenrother; Richard I Tapping
Journal:  J Biol Chem       Date:  2010-05-26       Impact factor: 5.157

Review 2.  Toll-like receptors and cancer.

Authors:  Seth Rakoff-Nahoum; Ruslan Medzhitov
Journal:  Nat Rev Cancer       Date:  2008-12-04       Impact factor: 60.716

Review 3.  Toll gates to periodontal host modulation and vaccine therapy.

Authors:  George Hajishengallis
Journal:  Periodontol 2000       Date:  2009       Impact factor: 7.589

Review 4.  Glial toll-like receptor signaling in central nervous system infection and autoimmunity.

Authors:  Pamela A Carpentier; D'Anne S Duncan; Stephen D Miller
Journal:  Brain Behav Immun       Date:  2007-10-24       Impact factor: 7.217

5.  Increased expression of endosomal members of toll-like receptor family abrogates wound healing in patients with type 2 diabetes mellitus.

Authors:  Kanhaiya Singh; Neeraj K Agrawal; Sanjeev K Gupta; Gyanendra Mohan; Sunanda Chaturvedi; Kiran Singh
Journal:  Int Wound J       Date:  2015-01-14       Impact factor: 3.315

6.  Toll-like receptor 4-myeloid differentiation factor 88 signaling contributes to ventilator-induced lung injury in mice.

Authors:  Huihua Li; Xiaoli Su; Xuebin Yan; Karla Wasserloos; Wei Chao; A Murat Kaynar; Zhao-Qian Liu; George D Leikauf; Bruce R Pitt; Li-Ming Zhang
Journal:  Anesthesiology       Date:  2010-09       Impact factor: 7.892

Review 7.  Toll-like receptors in neurodegeneration.

Authors:  Eitan Okun; Kathleen J Griffioen; Justin D Lathia; Sung-Chun Tang; Mark P Mattson; Thiruma V Arumugam
Journal:  Brain Res Rev       Date:  2008-09-12

8.  Analysis of proteinase-activated receptor 2 and TLR4 signal transduction: a novel paradigm for receptor cooperativity.

Authors:  Prasad Rallabhandi; Quan M Nhu; Vladimir Y Toshchakov; Wenji Piao; Andrei E Medvedev; Morley D Hollenberg; Alessio Fasano; Stefanie N Vogel
Journal:  J Biol Chem       Date:  2008-07-11       Impact factor: 5.157

9.  CD19, a response regulator of B lymphocytes, regulates wound healing through hyaluronan-induced TLR4 signaling.

Authors:  Yohei Iwata; Ayumi Yoshizaki; Kazuhiro Komura; Kazuhiro Shimizu; Fumihide Ogawa; Toshihide Hara; Eiji Muroi; Sangjae Bae; Motoi Takenaka; Toru Yukami; Minoru Hasegawa; Manabu Fujimoto; Yasushi Tomita; Thomas F Tedder; Shinichi Sato
Journal:  Am J Pathol       Date:  2009-07-02       Impact factor: 4.307

10.  New findings in osteoarthritis pathogenesis: therapeutic implications.

Authors:  Lia Pulsatelli; Olga Addimanda; Veronica Brusi; Branka Pavloska; Riccardo Meliconi
Journal:  Ther Adv Chronic Dis       Date:  2013-01       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.